相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。Host Factors Associated with Gut Mycobiome Structure
Natalia Szostak et al.
MSYSTEMS (2023)
Mapping the human gut mycobiome in middle-aged and elderly adults: multiomics insights and implications for host metabolic health
Menglei Shuai et al.
GUT (2022)
The fecal mycobiome in non-alcoholic fatty liver disease
Munevver Demir et al.
JOURNAL OF HEPATOLOGY (2022)
Long-term antibiotic exposure promotesmortality after systemic fungal infection by driving lymphocyte dysfunction and systemic escape of commensal bacteria
Rebecca A. Drummond et al.
CELL HOST & MICROBE (2022)
Intestinal Candida albicans Promotes Hepatocarcinogenesis by Up-Regulating NLRP6
Zherui Liu et al.
FRONTIERS IN MICROBIOLOGY (2022)
Fecal Fungi Dysbiosis in Nonalcoholic Fatty Liver Disease
Ningning You et al.
OBESITY (2021)
Hepatocellular carcinoma
Josep M. Llovet et al.
NATURE REVIEWS DISEASE PRIMERS (2021)
Factors determining the mortality in cirrhosis patients with invasive candidiasis: A systematic review and meta-analysis
Nipun Verma et al.
MEDICAL MYCOLOGY (2021)
How biological sex of the host shapes its gut microbiota
Francesco Valeri et al.
FRONTIERS IN NEUROENDOCRINOLOGY (2021)
Potential Probiotic Strains of Saccharomyces and Non-Saccharomyces: Functional and Biotechnological Characteristics
Pilar Fernandez-Pacheco et al.
JOURNAL OF FUNGI (2021)
Population study of the gut microbiome: associations with diet, lifestyle, and cardiometabolic disease
Rebecca L. Walker et al.
GENOME MEDICINE (2021)
Fungi of the human gut microbiota: Roles and significance
J. Christian Perez
INTERNATIONAL JOURNAL OF MEDICAL MICROBIOLOGY (2021)
The gut commensal fungus, Candida parapsilosis, promotes high fat-diet induced obesity in mice
Shanshan Sun et al.
COMMUNICATIONS BIOLOGY (2021)
Intestinal mycobiota in health and diseases: from a disrupted equilibrium to clinical opportunities
Xiaoyan Wu et al.
MICROBIOME (2021)
The gut microbiome: what the oncologist ought to know
K. A. Lee et al.
BRITISH JOURNAL OF CANCER (2021)
Gut microbial determinants of clinically important improvement in patients with rheumatoid arthritis
Vinod K. Gupta et al.
GENOME MEDICINE (2021)
Dynamic Changes of the Fungal Microbiome in Alcohol Use Disorder
Phillipp Hartmann et al.
FRONTIERS IN PHYSIOLOGY (2021)
Association of Insulin Resistance and Type 2 Diabetes With Gut Microbial Diversity A Microbiome-Wide Analysis From Population Studies
Zhangling Chen et al.
JAMA NETWORK OPEN (2021)
The role of gut mycobiome in health and diseases
Lin Zhang et al.
THERAPEUTIC ADVANCES IN GASTROENTEROLOGY (2021)
Fungi participate in the dysbiosis of gut microbiota in patients with primary sclerosing cholangitis
Sara Lemoinne et al.
GUT (2020)
Gut mycobiome of primary sclerosing cholangitis patients is characterised by an increase of Trichocladium griseum and Candida species
Malte Christoph Ruehlemann et al.
GUT (2020)
The Candida albicans exotoxin candidalysin promotes alcohol-associated liver disease
Huikuan Chu et al.
JOURNAL OF HEPATOLOGY (2020)
The gut-liver axis in liver disease: Pathophysiological basis for therapy
Agustin Albillos et al.
JOURNAL OF HEPATOLOGY (2020)
The global, regional, and national burden of cirrhosis by cause in 195 countries and territories, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017
Sadaf G. Sepanlou et al.
LANCET GASTROENTEROLOGY & HEPATOLOGY (2020)
The microbiome in rheumatology: Where are we and where should we go?
Julia Manasson et al.
ANNALS OF THE RHEUMATIC DISEASES (2020)
NLRP6 inflammasome
Runzhi Li et al.
MOLECULAR ASPECTS OF MEDICINE (2020)
Contribution of the Intestinal Microbiome and Gut Barrier to Hepatic Disorders
Daniel M. Chopyk et al.
GASTROENTEROLOGY (2020)
Gut microbiota and diabetes: From correlation to causality and mechanism
Wei-Zheng Li et al.
WORLD JOURNAL OF DIABETES (2020)
Therapeutic manipulation of gut microbiota by polysaccharides of Wolfiporia cocos reveals the contribution of the gut fungi-induced PGE2 to alcoholic hepatic steatosis
Shanshan Sun et al.
GUT MICROBES (2020)
Structural characterization of phosphorylated Pleurotus ostreatus polysaccharide and its hepatoprotective effect on carbon tetrachloride-induced liver injury in mice
Zhen Duan et al.
INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES (2020)
Sex Differences in Gut Microbiota
Yong Sung Kim et al.
WORLD JOURNAL OF MENS HEALTH (2020)
Hepatocellular Carcinoma Is Associated With Gut Microbiota Profile and Inflammation in Nonalcoholic Fatty Liver Disease
Francesca Romana Ponziani et al.
HEPATOLOGY (2019)
Gut microbiome analysis as a tool towards targeted non-invasive biomarkers for early hepatocellular carcinoma
Zhigang Ren et al.
GUT (2019)
Burden of liver diseases in the world
Sumeet K. Asrani et al.
JOURNAL OF HEPATOLOGY (2019)
The gut mycobiota: insights into analysis, environmental interactions and role in gastrointestinal diseases
Mathias L. Richard et al.
NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY (2019)
Autism Spectrum Disorders and the Gut Microbiota
Antonella Fattorusso et al.
NUTRIENTS (2019)
Intestinal Fungal Dysbiosis and Systemic Immune Response to Fungi in Patients With Alcoholic Hepatitis
Sonja Lang et al.
HEPATOLOGY (2019)
Impact of early events and lifestyle on the gut microbiota and metabolic phenotypes in young school-age children
Huanzi Zhong et al.
MICROBIOME (2019)
Gut pathobionts underlie intestinal barrier dysfunction and liver T helper 17 cell immune response in primary sclerosing cholangitis
Nobuhiro Nakamoto et al.
NATURE MICROBIOLOGY (2019)
Fungal dysbiosis in cirrhosis
Jasmohan S. Bajaj et al.
GUT (2018)
Modeling the epidemic of nonalcoholic fatty liver disease demonstrates an exponential increase in burden of disease
Chris Estes et al.
HEPATOLOGY (2018)
Global burden of NAFLD and NASH: trends, predictions, risk factors and prevention
Zobair Younossi et al.
NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY (2018)
The Intestinal Microbiome in Nonalcoholic Fatty Liver Disease
Puneet Puri et al.
CLINICS IN LIVER DISEASE (2018)
Fungal Diversity of Human Gut Microbiota Among Eutrophic, Overweight, and Obese Individuals Based on Aerobic Culture-Dependent Approach
Francis M. Borges et al.
CURRENT MICROBIOLOGY (2018)
CPT2 downregulation adapts HCC to lipid-rich environment and promotes carcinogenesis via acylcarnitine accumulation in obesity
Naoto Fujiwara et al.
GUT (2018)
Linking the gut and liver: crosstalk between regulatory T cells and mucosa-associated invariant T cells
Muhammad Atif et al.
HEPATOLOGY INTERNATIONAL (2018)
Protective effect of polysaccharide from Agaricus bisporus in Tibet area of China against tetrachloride-induced acute liver injury in mice
Yang Liu et al.
INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES (2018)
Investigating Colonization of the Healthy Adult Gastrointestinal Tract by Fungi
Thomas A. Auchtung et al.
MSPHERE (2018)
Alcoholic liver disease
Helmut K. Seitz et al.
NATURE REVIEWS DISEASE PRIMERS (2018)
Management of an Outbreak of Exophiala dermatitidis Bloodstream Infections at an Outpatient Oncology Clinic
Amber Vasquez et al.
CLINICAL INFECTIOUS DISEASES (2018)
Fungal microbiota dysbiosis in IBD
Harry Sokol et al.
GUT (2017)
Fungi in the healthy human gastrointestinal tract
Heather E. Hallen-Adams et al.
VIRULENCE (2017)
The Antioxidative, Antiaging, and Hepatoprotective Effects of Alkali-Extractable Polysaccharides by Agaricus bisporus
Shangshang Li et al.
EVIDENCE-BASED COMPLEMENTARY AND ALTERNATIVE MEDICINE (2017)
Intestinal fungi contribute to development of alcoholic liver disease
An-Ming Yang et al.
JOURNAL OF CLINICAL INVESTIGATION (2017)
The gut mycobiome of the Human Microbiome Project healthy cohort
Andrea K. Nash et al.
MICROBIOME (2017)
The Human Microbiota in Health and Disease
Baohong Wang et al.
ENGINEERING (2017)
Saccharomyces boulardii Administration Changes Gut Microbiota and Attenuates D-Galactosamine-Induced Liver Injury
Lei Yu et al.
SCIENTIFIC REPORTS (2017)
Crosstalk between the gut and the liver via susceptibility loci: Novel advances in inflammatory bowel disease and autoimmune liver disease
Xinyang Li et al.
CLINICAL IMMUNOLOGY (2017)
Intestinal microbiota contributes to individual susceptibility to alcoholic liver disease
M. Llopis et al.
GUT (2016)
Hepatoprotective effects of polysaccharide isolated from Agaricus bisporus industrial wastewater against CCl4-induced hepatic injury in mice
Jiafu Huang et al.
INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES (2016)
Alcohol and liver disease in Europe - Simple measures have the potential to prevent tens of thousands of premature deaths
Nick Sheron
JOURNAL OF HEPATOLOGY (2016)
Revised Estimates for the Number of Human and Bacteria Cells in the Body
Ron Sender et al.
PLOS BIOLOGY (2016)
Identification of Adjuvantic Activity of Amphotericin B in a Novel, Multiplexed, Poly-TLR/NLR High-Throughput Screen
Alex C. D. Salyer et al.
PLOS ONE (2016)
Microbiota-Modulated Metabolites Shape the Intestinal Microenvironment by Regulating NLRP6 Inflammasome Signaling
Maayan Levy et al.
CELL (2015)
NAFLD: A multisystem disease
Christopher D. Byrne et al.
JOURNAL OF HEPATOLOGY (2015)
Obesity changes the human gut mycobiome
M. Mar Rodriguez et al.
SCIENTIFIC REPORTS (2015)
The Gut Microbiota and Liver Disease
Cristina Llorente et al.
CELLULAR AND MOLECULAR GASTROENTEROLOGY AND HEPATOLOGY (2015)
Recent progress in the study of the interactions of amphotericin B with cholesterol and ergosterol in lipid environments
Daniel Michal Kaminski
EUROPEAN BIOPHYSICS JOURNAL WITH BIOPHYSICS LETTERS (2014)
Kingdom-Agnostic Metagenomics and the Importance of Complete Characterization of Enteric Microbial Communities
Jason M. Norman et al.
GASTROENTEROLOGY (2014)
SACCHAROMYCES CEREVISIAE FUNGEMIA, A POSSIBLE CONSEQUENCE OF THE TREATMENT OF CLOSTRIDIUM DIFFICILE COLITIS WITH A PROBIOTICUM
I. Santino et al.
INTERNATIONAL JOURNAL OF IMMUNOPATHOLOGY AND PHARMACOLOGY (2014)
L-Carnitine Prevents Progression of Non-Alcoholic Steatohepatitis in a Mouse Model with Upregulation of Mitochondrial Pathway
Hisashi Ishikawa et al.
PLOS ONE (2014)
Saccharomyces boulardii Administration Changes Gut Microbiota and Reduces Hepatic Steatosis, Low-Grade Inflammation, and Fat Mass in Obese and Type 2 Diabetic db/db Mice
Amandine Everard et al.
MBIO (2014)
Liver cirrhosis as a predisposing factor for esophageal candidiasis
Tzu-Ming Ou et al.
ADVANCES IN DIGESTIVE MEDICINE (2014)
Increased T Helper Type 17 Response To Pathogen Stimulation in Patients With Primary Sclerosing Cholangitis
Janosch Katt et al.
HEPATOLOGY (2013)
Primary sclerosing cholangitis
Gideon M. Hirschfield et al.
LANCET (2013)
Human intestinal microbiota composition is associated with local and systemic inflammation in obesity
Froukje J. Verdam et al.
OBESITY (2013)
Archaea and Fungi of the Human Gut Microbiome: Correlations with Diet and Bacterial Residents
Christian Hoffmann et al.
PLOS ONE (2013)
Aflatoxin B1-induced hepatocellular carcinoma in developing countries: Geographical distribution, mechanism of action and prevention (Review)
Abdu Selim Hamid et al.
ONCOLOGY LETTERS (2013)
The Gut Microbiome: A New Frontier in Autism Research
Jennifer G. Mulle et al.
CURRENT PSYCHIATRY REPORTS (2013)
The human mycobiome in health and disease
Lijia Cui et al.
GENOME MEDICINE (2013)
IL-1 receptor antagonist ameliorates inflammasome-dependent alcoholic steatohepatitis in mice
Jan Petrasek et al.
JOURNAL OF CLINICAL INVESTIGATION (2012)
Serum Metabolic Profiling Study of Hepatocellular Carcinoma Infected with Hepatitis B or Hepatitis C Virus by Using Liquid Chromatography-Mass Spectrometry
Lina Zhou et al.
JOURNAL OF PROTEOME RESEARCH (2012)
Gut microbiota composition correlates with diet and health in the elderly
Marcus J. Claesson et al.
NATURE (2012)
Human gut microbiome viewed across age and geography
Tanya Yatsunenko et al.
NATURE (2012)
Leaky gut and the liver: A role for bacterial transllocation in nonalcoholic steatohepatitis
Yaron Ilan
WORLD JOURNAL OF GASTROENTEROLOGY (2012)
Pathogenesis of primary sclerosing cholangitis
Marion J. Pollheimer et al.
BEST PRACTICE & RESEARCH CLINICAL GASTROENTEROLOGY (2011)
Correlation between gastrointestinal fungi and varying degrees of chronic hepatitis B virus infection
Yu Chen et al.
DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE (2011)
Hepatitis B virus x protein in the pathogenesis of hepatitis B virus-induced hepatocellular carcinoma
Michael C. Kew
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY (2011)
Succession of microbial consortia in the developing infant gut microbiome
Jeremy E. Koenig et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2011)
Linking Long-Term Dietary Patterns with Gut Microbial Enterotypes
Gary D. Wu et al.
SCIENCE (2011)
(1,3)-β-Glucans Activate Both Dectin-1 and NLRP3 Inflammasome in Human Macrophages
Paivi Kankkunen et al.
JOURNAL OF IMMUNOLOGY (2010)
Quantitative Real-Time PCR Analysis of Intestinal Regular Fungal Species in Fecal Samples From Patients With Chronic Hepatitis B Virus Infection
Renyong Guo et al.
LABMEDICINE (2010)
Influence of dominant bile duct stenoses and biliary infections on outcome in primary sclerosing cholangitis
Gerda Rudolph et al.
JOURNAL OF HEPATOLOGY (2009)
Liver cirrhosis caused by Exophiala dermatitidis
Ki Ho Hong et al.
JOURNAL OF MEDICAL MICROBIOLOGY (2009)
Systemic phaeohyphomycosis resembling primary sclerosing cholangitis caused by Exophiala dermatitidis
Erkin Oztas et al.
JOURNAL OF MEDICAL MICROBIOLOGY (2009)
A core gut microbiome in obese and lean twins
Peter J. Turnbaugh et al.
NATURE (2009)
Bacterial infections, sepsis, and multiorgan failure in cirrhosis
Puneeta Tandon et al.
SEMINARS IN LIVER DISEASE (2008)
Etiopathogenesis of primary sclerosing cholangitis
Roger Chapman et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2008)
TP53 mutations and hepatocellular carcinoma:: insights into the etiology and pathogenesis of liver cancer
S. P. Hussain et al.
ONCOGENE (2007)
PSC-IBD: a unique form of inflammatory bowel disease associated with primary sclerosing cholangitis
EV Loftus et al.
GUT (2005)
Anti-Saccharomyces cerevisiae antibodies (ASCA) and autoimmune liver diseases
P Muratori et al.
CLINICAL AND EXPERIMENTAL IMMUNOLOGY (2003)
Altered DNA mutation spectrum in aflatoxin B1-treated transgenic mice that express the hepatitis B virus X protein
CR Madden et al.
JOURNAL OF VIROLOGY (2002)
Dual effects of hepatitis B virus X protein on the regulation of cell-cycle control depending on the status of cellular p53
JY Ahn et al.
JOURNAL OF GENERAL VIROLOGY (2002)
Hepatitis B infection and aflatoxin biomarker levels in Gambian children
PC Turner et al.
TROPICAL MEDICINE & INTERNATIONAL HEALTH (2000)
Saccharomyces cerevisiae fungemia in a neutropenic patient treated with Saccharomyces boulardii
S Cesaro et al.
SUPPORTIVE CARE IN CANCER (2000)